Does dyslipidemia affect diabetes control in type 2 diabetic patients?

被引：0
|
作者：
Kyriazis, I. A.
Zervas, E.
Mytas, D.
Stougianos, P.
Lalousis, A.
Michas, D.
Paraskevopoulos, K.
Pirgakis, V.
Partheniou, Ch.
机构：
[1] Korinthos Gen Hosp, Lipid Outpatient Clin, Korinthos, Greece
[2] Korinthos Gen Hosp, Diabet Outpatient Clin, Korinthos, Greece
[3] Korinthos Gen Hosp, Dept Internal Med, Korinthos, Greece
[4] Korinthos Gen Hosp, Dept Cardiol, Korinthos, Greece
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71359-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [21] Metabolic control and diabetic retinopathy in patients with diabetes type 2
    Kosanovic-Jakovic, N.
    Resan, M.
    Dimitrijevic-Sreckovic, V.
    Vukosavljevic, M.
    Milenkovic, S.
    Colak, E.
    Risovic, D.
    Avramovic, S.
    Canovic, F.
    SPEKTRUM DER AUGENHEILKUNDE, 2010, 24 (03) : 157 - 161
  • [22] Treatment of dyslipidemia in type II diabetic dyslipidemia patients
    Alemao, EA
    Reckless, J
    Zhang, Q
    Yin, DD
    DIABETOLOGIA, 2002, 45 : A93 - A93
  • [23] Does prolonged aldosterone blockade affect adversely glucose control and arterial properties in type 2 diabetic patients?
    Shargorodsky, Marina
    Cernes, Relu
    Zimlichman, Reuven
    ENDOCRINE JOURNAL, 2010, 57 : S364 - S364
  • [24] Adiponectin and dyslipidemia in Caribbean patients with type 2 diabetes
    Foucan, L.
    Larifla, L.
    Deloumeaux, J.
    Maimaitiming, S.
    Velayoudom, F. -L.
    Hedreville, S.
    Blanchet, A.
    Bangou, J.
    Ezourhi, N.
    Aubert, R.
    Benabdallh, S.
    Marianne-Pepin, T.
    Rock, F.
    Donnet, J. -P.
    Fumeron, F.
    DIABETES & METABOLISM, 2011, 37 : A76 - A77
  • [25] DYSLIPIDEMIA IN PATIENTS WITH OSTEOARTHRITIS AND TYPE 2 DIABETES MELLITUS
    Oliinyk, M.
    OSTEOARTHRITIS AND CARTILAGE, 2014, 22 : S400 - S400
  • [26] Optimal treatment of dyslipidemia in patients with type 2 diabetes
    Taskinen, MR
    ATHEROSCLEROSIS: RISK FACTORS, DIAGNOSIS, AND TREATMENT, 2002, : 497 - 497
  • [27] Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan
    Abdel-Aal, Nazik M.
    Ahmad, Azmi T.
    Froelicher, Erika S.
    Batieha, Anwar M. S.
    Hamza, Musdaq M.
    Ajlouni, Kamel M.
    SAUDI MEDICAL JOURNAL, 2008, 29 (10) : 1423 - 1428
  • [28] Treating dyslipidemia in patients with type 2 diabetes mellitus
    Frank, Michelle L.
    Gerhardt, Annie M.
    NURSE PRACTITIONER, 2015, 40 (08): : 18 - 22
  • [29] Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes
    Tseng, Chin-Hsiao
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (08): : 1049 - 1055
  • [30] Pioglitazone is superior to acarbose in improving glycemic control and dyslipidemia in patients with type 2 diabetes
    Göke, B
    DIABETOLOGIA, 2000, 43 : A193 - A193
12345